Evolvus
Evolvus curates proprietary life sciences databases (bioactivity, ADME, genomics, protein degraders) and delivers data engineering, bioinformatics, and cheminformatics services to pharmaceutical, biotechnology, and scientific publishing clients globally.
- Company typePrivate
- Founded2001
- HeadquartersPune, India
- Headcount251–500
- GTM typeB2B
- OfferingServices
What Evolvus does
Evolvus Inc. is a privately held, bootstrapped life sciences data curation and research informatics company founded in 2001 by Aniket Ausekar and headquartered operationally between Pune, India and Nashua, New Hampshire, with a European office in Frankfurt am Main. The company builds proprietary curated databases across Compound Bioactivity, Metabolism/ADME, Protein Degraders, Conjugates, RNA, and Biomarkers (branded as Liceptor, Oncogen, Theme, Proximers, ADME, and Connector Base), and provides bespoke data curation, scientific data engineering, bioinformatics, cheminformatics, and clinical data services to pharmaceutical, biotechnology, and scientific publishing clients, including Fortune 500 life sciences companies.
The company's technology stack combines industrial-scale human annotation by trained pharmacologists, biochemists, molecular biologists, and organic chemists with conventional data engineering tooling — Apache Kafka for ETL, Snowflake/Amazon Redshift/Google BigQuery for warehousing, AWS S3/Google Cloud Storage/Azure Blob Storage for storage, and Tableau/Power BI/D3.js for visualization. Specialized proprietary tooling includes Markush structure indexing with daily patent updates and a molecular docking tool with an experimentally validated scoring algorithm, alongside in silico ADME-TOX prediction models for compound library screening.
Evolvus monetizes through quote-based, customized enterprise engagements delivered as databases, file sets, or API integrations (output formats including JSON, XML, RDF, SQL, SQL+SDF), targeting R&D informatics and preclinical/translational drug discovery teams. There are no publicly disclosed pricing tiers, no external funding events, no M&A activity, and no revenue figures in the available sources; the only stated scale metrics are 14 databases, 52 custom solutions, and 33 enterprise clients accumulated over 18+ years of operation, served via direct enterprise sales rather than digital marketing channels.
Evolvus firmographics
Firmographics- Name
- Evolvus
- Legal name
- Evolvus Inc.
- Website
- https://evolvus.com
- Company type
- Private
- Founded year
- 2001
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Evolvus curates proprietary life sciences databases (bioactivity, ADME, genomics, protein degraders) and delivers data engineering, bioinformatics, and cheminformatics services to pharmaceutical, biotechnology, and scientific publishing clients globally.
- Ownership category
- akta.pro rank
Evolvus industry classification
Industry- Product category
- Life Sciences Data Management
- NAICS
- Research and Development in the Physical, Engineering, and Life Sciences (54171), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- akta.pro primary industry
- Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D) (HLAGAJAC)
- akta.pro secondary industries
- Bioinformatics, Multi-Omics Data Analysis & Interpretation Services (HLAGANAI), Knowledge Management & Scientific Collaboration / Literature Intelligence (HLAGAJAN)
Keywords
Where Evolvus is headquartered
LocationHeadquarters
- HQ city
- Pune
- HQ country
- India
- HQ region
- Asia
Offices2 records
Markets served
Evolvus business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales
Revenue model
- Data Curation Services: Customized data curation services including Markush structures indexing, knowledge management, and annotation of chemical and biological data from patents and literature delivered as databases, files, or APIs
- Scientific Data Engineering Services: Scientific data engineering including data integration, validation, management, analytics, and ELN/LIMS consulting services
- Bioinformatics Services: Bioinformatics services for pharmaceutical and biotechnology industries including sequence analysis, microarray data analysis, genome annotation, homology modelling, and structure-based drug design
- Cheminformatics Services: Cheminformatics services including pharmacophore modelling, scaffold hopping, 3D-QSAR, in silico ADME-TOX prediction, compound library design, molecular informatics, and molecular docking
- Clinical Data Services: Clinical data management services including data integration, database design, electronic data capture, and clinical trial eligibility/consent form annotation
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
Evolvus product offering
Product offeringCore offering
Evolvus curates and delivers proprietary life sciences databases and bespoke data solutions for pharmaceutical and biotechnology R&D, covering Compound Bioactivity, Metabolism/ADME, Protein Degraders, Conjugates, RNA, and Biomarkers. The company also provides scientific data engineering, bioinformatics, cheminformatics, and clinical data management services delivered through a hybrid onshore/offshore model, with output delivered as databases, files, or APIs.
Product overview
Evolvus offers a portfolio of specialized life sciences databases designed for drug discovery and research. The core products include Liceptor (small molecule bioactivity), Oncogen (cancer genomics), Theme (biotransformation reactions), Proximers (protein degraders and MGB-BC datasets), ADME (pharmacokinetic endpoints), and Connector Base (data integration platform). These knowledge bases are complemented by a suite of services including data curation, research informatics, bioinformatics, cheminformatics, and clinical data services. The company positions itself as a provider of curated life sciences datasets covering Compound Bioactivity, Metabolism/ADME, Protein Degraders, Conjugates, RNA, and Biomarkers domains, enabling enterprises to take informed research-driven business decisions.
Differentiator
Problem solved
Functional benefit
Brands
- Liceptor: Small molecule bioactivity Database
- Oncogen
- Theme
- Proximers
- ADME
- Connector Base
Products and services
- Liceptor Small molecule bioactivity database providing curated compound bioactivity data for drug discovery research.
- Oncogen Cancer genomics curated knowledgebase providing integrated genomic data for oncology research.
- Theme Biotransformation reactions database covering metabolic pathways and biotransformation data.
- Proximers Protein degraders and MGB-BC datasets supporting targeted protein degradation research.
- ADME Curated pharmacokinetic (PK) endpoints database covering absorption, distribution, metabolism, and excretion data.
- Connector Base Knowledge asset platform for connecting and integrating life sciences datasets.
- Data Curation Services Customized indexing and annotation of chemical and biological data from patents and literature, including Markush structure indexing, knowledge management, and schema/format customizations, delivered as databases, files, or APIs for pharmaceutical R&D and scientific publishers.
- Research Informatics / Scientific Data Engineering Scientific data engineering services covering ETL pipelines, data warehousing, cloud storage, data lakes, validation, visualization, and custom reporting for research teams managing complex scientific data.
- Bioinformatics Services Bioinformatics services for pharmaceutical and biotechnology industries including sequence analysis, microarray data analysis, genome annotation, homology modelling, and structure-based drug design.
- Cheminformatics Services Cheminformatics services including pharmacophore modelling, scaffold hopping, 3D-QSAR, in silico ADME-TOX prediction, compound library design, molecular informatics, and molecular docking with experimentally validated scoring algorithms.
- Clinical Data Services Clinical data management services including data integration, database design, electronic data capture, and clinical trial eligibility and consent form annotation.
Quantifiable outcome
- Delivered 52 custom solutions to 33 happy clients over 18 years in business
Companies that use Evolvus
Customer profileSegments3 records
Ideal customer profiles3 records
Evolvus technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Evolvus partnerships and signals
Strategic signalScale indicators5 records
Recent moves5 records
Expansion highlights4 records
Evolvus competitors and assessment
Company assessmentBroad incumbents
- Clarivate: Public life sciences analytics and IP data company (Cortellis, Derwent, BioWorld) serving pharma R&D with curated datasets and analytics. Competes with Evolvus in scientific data curation and life sciences informatics at a much larger scale.
- Certara: Drug development services and biosimulation software (Phoenix, Simcyp) for pharma R&D. Comparable to Evolvus's clinical data services and ADME/PK modeling capabilities at greater scale.
- CAS (Chemical Abstracts Service): Division of ACS providing the world's most authoritative chemistry database (SciFinder/CAS SciFinder) with curated chemical substances, reactions, and bioactivity data. Directly competes in compound bioactivity and Markush indexing where Evolvus operates.
- BIOVIA (Dassault Systèmes): Enterprise scientific informatics suite (ELN, LIMS, biologics, chemistry) for life sciences R&D. Overlaps with Evolvus's scientific data engineering, ELN/LIMS consulting, and cheminformatics services but as part of a broader PLM platform.
- Elsevier (Reaxys): Major scientific publisher with Reaxys (chemistry) and Embase (biomedical) databases offering curated chemistry and pharmacology data. Directly comparable to Evolvus's cheminformatics and ADME data offerings but at much greater scale and with integrated platform.
Direct peers
- Dotmatics: Scientific R&D informatics platform offering data management, ELN, LIMS, and analytics for life sciences. Closely comparable to Evolvus's scientific data engineering and ELN/LIMS consulting services for pharma R&D customers.
- Schrödinger: Computational chemistry and molecular simulation platform for drug discovery, including molecular docking and ADME prediction — directly overlapping Evolvus's molecular docking tool, in silico ADME-TOX models, and cheminformatics services.
- Genedata: Enterprise bioinformatics platform for pharma R&D including Screener, Expressionist, and Biologics. Direct comparable to Evolvus's bioinformatics and multi-omics data analysis services targeting pharma and biotech.
- Collaborative Drug Discovery (CDD): Cloud-based drug discovery informatics platform with bioactivity database and research collaboration tools. Directly comparable to Evolvus's Liceptor bioactivity database and research informatics offerings for pharma/biotech.
Regional players
- Aragen Life Sciences: India-based CRO with informatics and data curation services for pharma R&D. Comparable as a geographically-overlapping competitor with hybrid onshore/offshore delivery model, similar to Evolvus's Pune-based operations.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Evolvus financial estimates
Financial estimateRevenue estimate
Valuation estimate
Evolvus leadership team
Management profileNumber of profiles
Profiles1 record
Evolvus funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Evolvus M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Evolvus
What does Evolvus do?
Evolvus curates and delivers proprietary life sciences databases and bespoke data solutions for pharmaceutical and biotechnology R&D, covering Compound Bioactivity, Metabolism/ADME, Protein Degraders, Conjugates, RNA, and Biomarkers. The company also provides scientific data engineering, bioinformatics, cheminformatics, and clinical data management services delivered through a hybrid onshore/offshore model, with output delivered as databases, files, or APIs.
Is Evolvus a public or private company?
Evolvus is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Evolvus founded?
Evolvus was founded in 2001. It employs 251 to 500 people.
Where is Evolvus based?
Evolvus is headquartered in Pune, India, in the Asia region.
How does Evolvus make money?
Five revenue lines are on record. Data Curation Services are the primary driver. The others are scientific Data Engineering Services, bioinformatics Services, cheminformatics Services and clinical Data Services.
Who are Evolvus's main competitors?
Broad incumbents on record are Clarivate, Certara, CAS (Chemical Abstracts Service), BIOVIA (Dassault Systèmes) and Elsevier (Reaxys). Direct peers are Dotmatics, Schrödinger, Genedata and Collaborative Drug Discovery (CDD). Aragen Life Sciences is listed as a regional player.
Does Evolvus have an API?
No public API is recorded for Evolvus.
What industry is Evolvus in?
Evolvus's product category is Life Sciences Data Management. Its primary akta.pro industry code is HLAGAJAC, Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D), with a secondary code of HLAGANAI, Bioinformatics, Multi-Omics Data Analysis & Interpretation Services. Its NAICS code is 54171.